News
Brief news reports on Tuberculosis
By
World Health Organization
Published: Nov. 21, 2023, 8:31 p.m.·
Tags:
Global TB response
Over 130 participants from countries, partners and civil society came together at the Global Meeting of the Working Group on Public-Private Mix for TB prevention and care (PPM Working Group). The meeting, held on 12 November in Paris, France, was convened by the World Health Organization (WHO) and Stop TB Partnership with support from the US Agency for International Development (USAID) and the Global Fund. The meeting was organized on the sidelines of the 53rd Union World Conference on Lung Health.
Read More →
By
Pooja Toshniwal Paharia
Published: Nov. 20, 2023, 3:45 p.m.·
Tags:
Drug-resistant TB,
Treatment
In a recent study published in The Lancet Respiratory Medicine, researchers reported the TB-PRACTECAL clinical trial outcomes, which evaluated the efficacy and safety of oral bedaquiline, linezolid, and pretomanid (BPaL)-based regimens for pulmonary tuberculosis resistant to rifampicin.
Read More →
By
International Union Against Tuberculosis and Lung Disease
Published: Nov. 18, 2023, 8:33 p.m.·
Tags:
Global TB response
After three years being held virtually due to the COVID-19 pandemic, the 2023 Union World Conference on Lung Health (Union Conference) took place in-person on 15-18 November 2023 in Paris, France under the theme 'Transforming evidence into practice'.
Read More →
By
Chapal Mehra
Published: Nov. 16, 2023, 11 p.m.·
Tags:
Global TB response,
Access,
Advocacy
As yet another conference kicks off, it underscores the way such collaborations to end the infectious disease only serve to maintain the colonial status quo.
Read More →
By
TB Alliance
Published: Nov. 16, 2023, 10:46 p.m.·
Tags:
Drug-susceptible TB,
Drug-resistant TB,
Treatment
A combination of a new experimental compound, TBAJ-876, with pretomanid and linezolid, has the potential to become a 'universal TB regimen', shortening and improving treatment for both drug-sensitive and drug-resistant TB.
Read More →
By
Desmond Tutu TB Centre, Stellenbosch University
Published: Nov. 16, 2023, 8:29 p.m.·
Tags:
Drug-resistant TB,
Prevention
Two new clinical trials find first-ever safe and effective treatment to prevent multidrug-resistant TB in both children and adults.
Read More →
By
endTB
Published: Nov. 15, 2023, 10:02 p.m.·
Tags:
Drug-resistant TB,
Treatment
endTB clinical trial offers multiple new shortened drug regimens to treat adults and children with multidrug–resistant TB.
Read More →
By
TB Alliance
Published: Nov. 15, 2023, 8:37 p.m.·
Tags:
Drug-resistant TB,
Treatment
Results of LIFT-TB operational research on BPaL regimen for treating drug-resistant TB in Central and Southeast Asia.
Read More →
Page 1 of 866 · Total posts: 10
1
2
Last→